Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections

By N. Friedman, K. Kaye, J. Stout, Sarah A McGarry, Sharon L. Trivette, Jane P. Briggs, Wanda Lamm, C. Clark, J. Macfarquhar, Aaron Walton and 2 more. Annals of Internal Medicine, 2002

1,585 citations recorded by the source corpus.

Context Bloodstream infections are traditionally classified as community-acquired or hospital-acquired (nosocomial). Ideally, these classifications guide initial diagnostic and management decisions. As out-of-hospital care grows more complex, do we need finer classifications? Contribution This prospective study from three hospitals in North Carolina shows that about one third of patients with bloodstream infections have had recent contact with the health care system (health careassociated infections) through nursing homes, home health care programs, outpatient intravenous therapy, or recent hospitalizations. Staphylococcus aureus and intravascular devices were the most common pathogen and source, respectively, for both health careassociated and nosocomial infections. Implications Health careassociated infections often resemble nosocomial infections, a fact to be considered in selecting empirical antibiotic therapy for these infections. The Editors A recent review (1) found that nearly equal proportions of bacteremias were community acquired (48%) and nosocomial (52%). In the 1970s, by contrast, nearly two thirds of 500 bacteremic episodes were nosocomial (2). At present, patients with complicated conditions, such as cancer or renal failure, are routinely cared for in outpatient settings, yet such patients are still categorized as having community-acquired infections when they are admitted to the hospital with bloodstream infection. The Centers for Disease Control and Prevention (CDC) surveillance definitions include only nosocomial infection (3); infections that are not nosocomial are considered to be community acquired by default. The term nosohusial has been proposed to describe infections occurring in patients who are receiving care at home (4). However, this term applies only to illnesses in patients who receive care at home; it excludes patients in nursing homes and rehabilitation centers, patients receiving dialysis, and patients receiving chemotherapy in physicians' offices. Although the authors of a recent study (5) proposed creating a more inclusive category, health careassociated infection, no consensus definition exists for this group of infections. We sought to devise a new classification scheme for bloodstream infections that distinguishes among and compares patients with community-acquired, health careassociated, and nosocomial infections. Methods This prospective cohort study was done at Duke University Medical Center (Durham, North Carolina), Durham Regional Hospital (Durham, North Carolina), and Nash General Hospital (Rocky Mount, North Carolina). Approval of the study protocol was obtained from the institutional review boards at each hospital, which waived the requirement for obtaining informed consent. Patient Selection Daily microbiology laboratory reports were reviewed and case-report forms were completed by either a physician or an infection-control practitioner on consecutive adult patients who were admitted to the hospital with bloodstream infections or developed bloodstream infections during hospitalization. Patients younger than 17 years of age and patients who visited the emergency department but were not hospitalized were excluded. Data Collection We collected data on demographic characteristics, medication use, blood cultures, comorbid medical conditions, results of antimicrobial susceptibility testing, and dates of admission and discharge or death. Mortality data were retrieved from medical records and a Social Security death registry Web site (6). The medical record was the gold standard for assessing mortality, and we searched for deaths by Social Security number only if the medical record was not definitive. Follow-up continued for a maximum of 6 months after enrollment. A bloodstream-infection episode was defined by the first set of positive blood cultures in a series or by any new positive blood culture set occurring more than 48 hours after a previous positive result, unless it was clear to the investigator that the new positive culture was part of the previous episode [2]. To distinguish between true bloodstream infections and episodes of contamination, each positive blood culture was assessed critically by one investigator. All isolates were categorized as 1) true-positive, 2) contaminated, or 3) of unknown clinical significance. The determination was made after review of the patient's clinical history, physical findings, temperature at the time of blood culture, leukocyte count, number of positive blood cultures, results of cultures of specimens from other sites, imaging results, histopathologic findings, clinical course, and response to therapy (1). Nosocomial bloodstream infection was defined by a positive blood culture obtained from patients who had been hospitalized for 48 hours or longer (3). If a patient was transferred from another hospital, the duration of inpatient stay was calculated from the date of the first hospital admission. Health careassociated bloodstream infection was defined by a positive blood culture obtained from a patient at the time of hospital admission or within 48 hours of admission if the patient fulfilled any of the following criteria: Received intravenous therapy at home; received wound care or specialized nursing care through a health care agency, family, or friends; or had self-administered intravenous medical therapy in the 30 days before the bloodstream infection. Patients whose only home therapy was oxygen use were excluded. Attended a hospital or hemodialysis clinic or received intravenous chemotherapy in the 30 days before the bloodstream infection. Was hospitalized in an acute care hospital for 2 or more days in the 90 days before the bloodstream infection. Resided in a nursing home or long-term care facility. Community-acquired bloodstream infection was defined by a positive blood culture obtained at the time of hospital admission or within the 48 hours after hospital admission for patients who did not fit the criteria for a health careassociated infection. Information about comorbid medical conditions, such as diabetes, chronic obstructive pulmonary disease, liver disease, active cancer, transplantation, or HIV infection, was obtained through medical record review. Active cancer was defined as a solid tumor or hematologic malignancy (except squamous-cell or basal-cell skin cancer) diagnosed or treated in the past 5 years. Vascular disease was defined by the clinical documentation of at least one of the following: coronary artery disease, cerebrovascular disease, peripheral vascular disease, or aortic aneurysm. Renal failure was defined as a serum creatinine concentration greater than 177 mol/L (>2.00 mg/dL). Factors predisposing to infection, such as chemotherapy, immunosuppressive therapy, and radiation therapy, were considered to be present if they had been administered within 30 days of the bloodstream infection. Neutropenia was defined as an absolute neutrophil count of less than 500 cells/mm3 within 30 days before the bloodstream infection. Immunosuppressive therapy included treatment with steroids, cyclophosphamide, azathioprine, methotrexate, mycophenolate mofetil, and calcineurin inhibitors. Sources of bloodstream infection were designated as culture confirmed (if the same organism was isolated from another site) or suspected (if clinical findings of infection were seen without microbiological proof). Primary bloodstream infections including intravascular deviceassociated infections were defined according to the National Nosocomial Infections Surveillance System (3, 7). Secondary bloodstream infection was declared to be present when an organism isolated from a blood culture was related to an infection at another site, as defined by both CDC and other published criteria (3, 8). Microbiology All isolates from patients were identified and speciated by using standard microbiologic techniques (2). Antimicrobial susceptibility testing was done according to National Committee for Clinical Laboratory standards (9). Statistical Analysis Statistical analysis was done by using SAS software, version 8.2 (SAS Institute, Inc., Cary, North Carolina). Distributions of baseline characteristics were analyzed by using the Wilcoxon rank-sum test for continuous variables. The chi-square test was used to assess associations among categorical variables, with 3 2 tables broken down into three 2 2 tables for pairwise comparisons. If any expected value for a cell in one of the 2 2 tables was less than 5, the Fisher exact test was used and two-sided P values were reported. Associations between epidemiologic categories of infection and other variables were analyzed by using conditional fixed-effects logistic regression. Dummy variables (0/1) were used to represent two of the three hospitals (the third hospital being the baseline) as well as two of the three epidemiologic categories of infection, thereby adjusting for clustering of epidemiologic factors and outcomes by hospital site. This technique was validated by comparison with MantelHaenszel chi-square. A P value less than 0.05 was considered statistically significant. Role of the Funding Source The funding source had no role in the collection, analysis, or interpretation of the data or in the decision to submit the manuscript for publication. Results Between 16 October 2000 and 28 February 2001, a total of 1175 positive blood cultures were detected at the three study hospitals. Of these 1175 cultures, 476 were the result of contamination, 655 represented true bloodstream infections, and 44 were of unknown clinical significance. Seven of the 1175 were excluded from analysis because the patients were not admitted to the hospital. Coagulase-negative staphylococci (66%), gram-positive rods (16%), and mixed skin flora (9%) constituted most of the contaminants. Either coagulase-negative staphylococci (64%) or yeast (11%) was present in three fourths of cases classified as bloodstream infection of unkno

Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/361530a9ab3087dfe3c26a854214c5e80e6bef8a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

  1. 古谷 良輔
  2. 山口 和将

In Critical Care and Intensive Care Medicine

  1. 古谷 良輔
  2. 山口 和将

In Molecular Medicine

  1. Robin Patel
  2. 古谷 良輔
  3. 山口 和将

Citations in the corpus